Protalix BioTherapeutics
PLX
#8699
Rank
NZ$0.30 B
Marketcap
NZ$3.83
Share price
0.92%
Change (1 day)
-13.72%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): NZ$0.02662

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.03494. In 2024 the company made an earnings per share (EPS) of NZ$0.06988 a decrease over its 2023 EPS that were of NZ$0.21.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.02662-61.9%
2024NZ$0.06988-66.67%
2023NZ$0.21-138.71%
2022NZ-$0.54-50%
2021NZ-$1.08181.82%
2020NZ-$0.38-82.11%
2019NZ-$2.15-31.67%
2018NZ-$3.14-72.31%
2017NZ-$11.36124.14%
2016NZ-$5.07-147.54%
2015NZ$10.66-290.62%
2014NZ-$5.596.67%
2013NZ-$5.24130.77%
2012NZ-$2.27-69.77%
2011NZ-$7.5119.44%
2010NZ-$6.29-12.2%
2009NZ-$7.1636.67%
2008NZ-$5.24-37.5%
2007NZ-$8.3950%
2006NZ-$5.593.23%
2005NZ-$5.42138.46%
2004NZ-$2.27-74%
2003NZ-$8.74-0%
2002NZ-$8.74-50%
2001NZ-$17.47233.33%
2000NZ-$5.24-84.21%
1999NZ-$33.19-24%
1998NZ-$43.68-600%
1997NZ$8.74-16.67%
1996NZ$10.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.38 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$8.42 24,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.19-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.17 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel